CardioDynamics Reports Second Fiscal Quarter 20...(Gross margin 37...),Health

Date:7/9/2009

Gross margin 3,767 4,408 7,484 8,395 Research and development 370 370 765 684 Selling and marketing 3,725 3,721 7,295 7,443 General and administrative 816 761 1,589 1,532 Amortization of intangible assets 5 32 31 64 Loss from operations (1,149) (476) (2,196) (1,328) Other expense, net (277) (192) (502) (358) Loss before income taxes and minority interest (1,426) (668) (2,698) (1,686) Minority interest in income of subsidiary (19) (11) (68) (145) Income tax provision (41) (53) (180) (516) Income from discontinued operations - - - 127 Net loss $(1,486) $(732) $(2,946) $(2,220) Net loss per common share: Basic and diluted $(0.20) $(0.10) $(0.40) $(0.31) Weighted-average shares used in per share calculation: Basic and diluted 7,395 7,193 7,345 7,150

    Selected Consolidated Balance Sheet Data
                                                   May 31,       November 30,
                                                    2009             2008
    Cash and cash equivalents                      $4,187           $6,306
    Accounts receivable, net                        3,582            3,918
    Inventory, net                                  1,352            1,490
    Total current assets                            9,445           12,138
    Long-term assets                                3,583            3,428
    Total assets                                   13,028           15,566
    Total current liabilities                       3,912            4,499

'/>"/>
SOURCE  CardioDynamics
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 
Related medicine news :

1. CardioDynamics Announces Third Quarter 2007 Conference Call and Webcast
2. CardioDynamics Announces Strategic Alliance With Leading Medical Equipment Manufacturer in India
3. CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007
4. CardioDynamics Board of Directors Proposes Reverse Split 1:7 of Companys Shares
5. CardioDynamics Reports 22% Revenue Growth in First Quarter 2008
6. CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting
7. CardioDynamics Announces Second Quarter 2008 Conference Call and Webcast
8. CardioDynamics Reports Second Fiscal Quarter 2008 Results, 18% Revenue Increase for First Half 2008
9. CardioDynamics Announces Investors Retain $5.25 Million 8% Convertible Debt Securities
10. CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008
11. CardioDynamics Reports First Quarter 2009 Results